EPIGENETIC MODIFICATIONS OF GABA NEURONS IN PSYCHOSIS
EPIGENETIC MODIFICATIONS OF GABA NEURONS IN PSYCHOSIS
批准号:
7386765
负责人:
Rajiv Pandit Sharma
金额:
$17.56万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31
关键词:
Antisense OligonucleotidesBindingBinding ProteinsBiological AssayBrainBrain-Derived Neurotrophic FactorCell LineCharacteristicsChromatinChromatin StructureCo-ImmunoprecipitationsCpG IslandsDNADNA BindingDNA MethylationDNA SequenceDNA-Binding ProteinsDNA-Protein InteractionDataDevelopmentDiseaseDoseDown-RegulationEnzymesEpigenetic ProcessExonsGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenomeHistone Deacetylase InhibitorHistonesHypermethylationInterneuronsInterventionK-Series Research Career ProgramsLaboratoriesLocationMeasuresMembraneMessenger RNAMethionineMethodsMethyl-CpG-Binding Protein 2MethylationMitoticModificationMolecularMusMutationNeocortexNeuron-Specific EnolaseNeuronsOutputPatientsPharmaceutical PreparationsPharmacological TreatmentPhenotypePlayProteinsPsychotic DisordersRecording of previous eventsReportingRepressor ProteinsRett SyndromeReverse Transcriptase Polymerase Chain ReactionRoleSchizophreniaSiteStandards of Weights and MeasuresStimulusTrainingValproic AcidVariantWestern BlottingWorkbisulfitechromatin remodelinggamma-Aminobutyric Acidinhibitor/antagonistmRNA Expressionmolecular pathologynovel therapeuticspromoterresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The GABA intemeuron plays a central role in integrating cortical output and is emerging as a major locus of schizophrenia molecular pathology. Reelin (RELN), GAD67 and DNA methylating enzyme (DNMT1) are all expressed in GABA interneurons, and are each abnormally regulated in schizophrenic brain. Further, DNMT1 is a critical component of the epigenetic regulatory cascade, now shown to play an essential role in neuronal gene expression. We have earlier reported on the effects of epigenetic modifiers (DNA methylation, chromatin structure, and methylated-DNA binding proteins) on the levels of RELN and GAD67 expression. This career development award will extend these observations using primary neuronal cultures (PNC) to describe variations in epigenetic modifications of the RELN and GAD67 promoters resulting from pharmacological treatment and membrane depolarization. Supporting the use of PNCs, we and others have observed El4 mouse neuron cultures to be predominantly GABAergic in phenotype (co-expressing RELN, GAD and DNMT1). Our first objective, using these homogenous neuronal cultures, will be to analyze DNA methylation, local chromatin structure and promoter DNA-protein interactions in response to pharmacological treatments with known epigenetic effects, specifically L-methionine, a hypermethylating stimulus, and histone deactylase (HDAC) inhibitors such as valproic acid. Supporting this first objective is our earlier demonstration that L-methionine down regulates RELN and GAD67 mRNA expression as a consequence of epigenetic modifications along their promoters, and this is reversed by the application of valproic acid. Our second objective will be to examine the effects of membrane depolarization on epigenetic modification of depolarization inducible promoters within these GABAergic neurons. We will apply antisense oligonucleotide strategies to down regulate epigenetic repressor proteins such as DNMT1 and MeCP2 to dissect their contribution to depolarization induced gene transcription. Supporting this second objective, we have now shown that antisense induced down regulation of DNMT1 mRNA and protein will result in significant increases in RELN mRNA expression. Also, we have preliminary data indicating robust changes in GAD67 and DNMT1 mRNA in response to depolarization.
With this KO1 career development award, the candidate seeks training in focused methods in the molecular study of epigenetic gene regulation. Because epigenetic mechanisms are modifiable by drug interventions, this work has immediate relevance to the development of novel therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PARP-mediated gene regulation in alcohol drinking behavior
-
批准号:10204859
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Rajiv Pandit Sharma
-
依托单位:
PARP-mediated gene regulation in alcohol drinking behavior
-
批准号:10552525
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Rajiv Pandit Sharma
-
依托单位:
PARP-mediated gene regulation in alcohol drinking behavior
-
批准号:9898316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Rajiv Pandit Sharma
-
依托单位:
The H3K9 HISTONE SWITCH; 'LEVELS' IN SCHIZOPHRENIA BLOOD AND BRAIN
-
批准号:8370339
-
项目类别:
-
资助金额:$48.76万
-
财政年份:2012
-
负责人:Rajiv Pandit Sharma
-
依托单位:
The H3K9 HISTONE SWITCH; 'LEVELS' IN SCHIZOPHRENIA BLOOD AND BRAIN
-
批准号:8857254
-
项目类别:
-
资助金额:$45.9万
-
财政年份:2012
-
负责人:Rajiv Pandit Sharma
-
依托单位:
The H3K9 HISTONE SWITCH; 'LEVELS' IN SCHIZOPHRENIA BLOOD AND BRAIN
-
批准号:8517192
-
项目类别:
-
资助金额:$45.87万
-
财政年份:2012
-
负责人:Rajiv Pandit Sharma
-
依托单位:
EPIGENETIC MODIFICATIONS OF GABA NEURONS IN PSYCHOSIS
-
批准号:7234306
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2005
-
负责人:Rajiv Pandit Sharma
-
依托单位:
EPIGENETIC MODIFICATIONS OF GABA NEURONS IN PSYCHOSIS
-
批准号:7619304
-
项目类别:
-
资助金额:$17.72万
-
财政年份:2005
-
负责人:Rajiv Pandit Sharma
-
依托单位:
EPIGENETIC MODIFICATIONS OF GABA NEURONS IN PSYCHOSIS
-
批准号:6866886
-
项目类别:
-
资助金额:$16.92万
-
财政年份:2005
-
负责人:Rajiv Pandit Sharma
-
依托单位:
EPIGENETIC MODIFICATIONS OF GABA NEURONS IN PSYCHOSIS
-
批准号:7033064
-
项目类别:
-
资助金额:$17.06万
-
财政年份:2005
-
负责人:Rajiv Pandit Sharma
-
依托单位:
NONTOLERANCE TO NEUROLEPTIC--SUBTYPING SCHIZOPHRENIA
-
批准号:2248454
-
项目类别:
-
资助金额:$7.65万
-
财政年份:1993
-
负责人:Rajiv Pandit Sharma
-
依托单位:
DA' NONTOLERANCE' TO NEUROLEPTIC; SUBTYPING SCHIZOPHRENI
-
批准号:2248453
-
项目类别:
-
资助金额:$1.33万
-
财政年份:1993
-
负责人:Rajiv Pandit Sharma
-
依托单位:
NONTOLERANCE TO NEUROLEPTIC--SUBTYPING SCHIZOPHRENIA
-
批准号:2460339
-
项目类别:
-
资助金额:$9.37万
-
财政年份:1993
-
负责人:Rajiv Pandit Sharma
-
依托单位:
DOPAMINE NONTOLERANCE TO NEUROLEPTICS & SCHIZOPHRENIA
-
批准号:3475831
-
项目类别:
-
资助金额:$8.93万
-
财政年份:1993
-
负责人:Rajiv Pandit Sharma
-
依托单位:
NONTOLERANCE TO NEUROLEPTIC--SUBTYPING SCHIZOPHRENIA
-
批准号:2248456
-
项目类别:
-
资助金额:$9.01万
-
财政年份:1993
-
负责人:Rajiv Pandit Sharma
-
依托单位:
NONTOLERANCE TO NEUROLEPTIC--SUBTYPING SCHIZOPHRENIA
-
批准号:2248455
-
项目类别:
-
资助金额:$9.96万
-
财政年份:1993
-
负责人:Rajiv Pandit Sharma
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: